Edgewood Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Edgewood Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,000	Closed	-$504K	–	88
2021 Q3	$504K	Hold	25,000	–	–	﹤0.01%	68
2021 Q2	$933K	Hold	25,000	–	–	﹤0.01%	54
2021 Q1	$639K	Hold	25,000	–	–	﹤0.01%	61
2020 Q4	$551K	Hold	25,000	–	–	﹤0.01%	62
2020 Q3	$450K	Hold	25,000	–	–	﹤0.01%	65
2020 Q2	$635K	Hold	25,000	–	–	﹤0.01%	54
2020 Q1	$459K	Hold	25,000	–	–	﹤0.01%	58
2019 Q4	$551K	Buy	+25,000	New	+$503K	﹤0.01%	61

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Edgewood Management's DRNA Position: Q4 2021 in Review

Edgewood Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 25,000 shares — an estimated $504K sold.

Edgewood Management first reported a position in DRNA in Q4 2019 and held it in 8 quarters. The position peaked at $933K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Edgewood Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Edgewood Management sold 25,000 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $504K.
Edgewood Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 8 quarters.
Edgewood Management's Dicerna Pharmaceuticals, Inc. position peaked at $933K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Edgewood Management's 13F filing for Q4 2021, filed 11 Feb 2022.